Finnish🇫🇮 innovation Solid IO enables faster access to personalised cancer therapies.

[petrig]

The company's "tumour-on-a-chip" technology allows for drug testing directly on a patient's own cancer cells and immune system, helping to predict the effectiveness of different therapies. This method provides doctors with the ability to design care plans for each patient individually, reducing the uncertainty and trial-and-error typically associated with cancer therapy.

helsinki.fi/en/helsinki-inn...